Fatima Jabri, Author at Zahrawi

Dubai, UAE – December 9, 2024 – Zahrawi Group, a leading provider in healthcare solutions across the GCC, on Wednesday announced the successful official inauguration of its new state-of-the-art 38,000 square foot Distribution Centre, strategically located opposite Terminal 3 of Dubai International Airport. This milestone marks a significant chapter in the Group’s growth journey and its commitment to operational excellence.

The opening ceremony, held on November 27, 2024, brought together Zahrawi Group’s leadership, including Chairman Isam M. Al-Muhaidib, alongside key partners, customers, representatives from governmental institutions, and Zahrawi’s senior management team. The guests were welcomed to a comprehensive tour of the facility, which showcased the advanced technologies and enhancements designed to optimise efficiency and scalability.

Guests also got the opportunity to explore the facility’s key features, including an advanced inventory management system, temperature-controlled storage, automated loading bays, and high-capacity order processing stations. Zahrawi Group’s leadership highlighted how these innovations improve operational accuracy, reduce turnaround times, and ensure the highest quality standards, positioning the facility as a benchmark in healthcare logistics across the region.

Abdulrahman Ramadan, Group CEO, highlighted the strategic significance of the new facility, emphasising how the Distribution Centre’s advanced technologies and increased capacity position Zahrawi Group to address the evolving needs of the healthcare industry. He underscored the company’s commitment to operational excellence and its focus on delivering exceptional value to its partners and customers, ultimately benefiting patients.

“This facility significantly enhances our capacity to meet the evolving needs of the healthcare sector. With cutting-edge technology and streamlined workflows, we are now better equipped than ever to ensure faster deliveries, greater accuracy, and the highest quality standards. This investment reinforces our position as a trusted partner in healthcare solutions across the GCC,” he said.

Isam M. Al-Muhaidib, Chairman of Zahrawi Group, reflected on the broader significance of this achievement. “This distribution centre is a reflection of our vision to innovate and elevate our operations to meet the growing demands of the healthcare sector. It is not just an investment in infrastructure but also a testament to the trust and partnerships we’ve built over the years. This milestone strengthens our foundation and supports our mission to empower healthcare providers and improve patient outcomes across the GCC,” he stated.

Established in 1989, Zahrawi Group is a pioneer medical devices and life science distributor in the Gulf, with a presence in UAE, KSA, Qatar, Oman, and Bahrain. Specialising in surgical, medical, nuclear medicine, diagnostic, and analytical lab solutions, Zahrawi Group is known for driving progress in the healthcare sector by leveraging innovation and collaboration. The new distribution centre will help the company support healthcare providers and improve patient outcomes across the GCC.

“Zahrawi Group remains dedicated to driving progress in the healthcare sector by leveraging innovation and collaboration. Our new distribution centre is a cornerstone of this commitment, enabling the company to support healthcare providers and improve patient outcomes across the GCC. This achievement reinforces the Group’s mission to improve peoples’ lives by leading with excellence, integrity, and unwavering dedication to its stakeholders,” added Abdulrahman Ramadan, Group CEO.

About Zahrawi Group:

Established in 1989, Zahrawi Group is a pioneer medical devices and life science distributor in the Gulf region, with a presence in UAE, KSA, Qatar, Oman, and Bahrain. Zahrawi Group is specialized in surgical, cardiovascular, medical, nuclear medicine, diagnostic, and analytical lab solutions, and was founded with a vision to be the leading and most trusted partner in the GCC.

Zahrawi Group is committed to improving people’s lives by introducing innovative healthcare products, smart solutions, and outstanding services.

To learn more, connect on:

X (Twitter: https://twitter.com/ZahrawiGroup),

LinkedIn (https://www.linkedin.com/company/zahrawi-group),

Facebook (https://www.facebook.com/zahrawigroup),

Instagram (https://www.instagram.com/zahrawi_group/?hl=en),

And Youtube (https://www.youtube.com/channel/UCBj5KkcupdKnukeVmf5xzLQ).

Zahrawi Group, in partnership with Medtronic, participated in the Robotic Surgery Collaboration Summit 2024 held at Cleveland Clinic Abu Dhabi. This event brought together leading experts and institutions to explore the latest advancements in robotic surgery, focusing on areas such as abdominal wall reconstruction, bariatric surgery, colorectal and gastrointestinal procedures, emergency surgery, hepato-pancreato-biliary techniques, and digital surgery.

The summit provided a platform for sharing knowledge through panel discussions, interactive presentations, and case studies. In addition to clinical advancements, it addressed topics like leadership, entrepreneurship, and innovation in the surgical field, aiming to equip participants with the tools to advance robotic surgery and foster mentorship across the region.

Zahrawi Group’s Surgical team showcased Medtronic’s Hugo™ RAS Platform, Covidien Signia™ stapling devices, and Covidien Sonicision™ at the event. The Hugo™ RAS Platform is a next-generation system designed to enhance precision and flexibility in minimally invasive procedures. The Covidien Signia™ staplers provide adaptive feedback and precision for a range of surgical needs, while the Covidien Sonicision™ cordless ultrasonic dissection tool improves efficiency and precision during surgeries.

These demonstrations reflected Zahrawi Group’s commitment to advancing surgical technology in the region and improving patient outcomes. Our partnership with Medtronic continues to play a vital role in bringing innovative solutions to healthcare providers and supporting the development of advanced surgical practices.